Clinicopathological study of scirrhous hepatocellular carcinoma
Clinicopathological study of scirrhous hepatocellular carcinoma
复制标题
DOI:
10.1111/j.1440-1746.2006.04372.x
复制
发表时间:
2006-09-01
影响因子:
4.1
通讯作者:
Kojiro, Masamichi
中科院分区:
文献类型:
--
作者:
Kurogi, Mina;Nakashima, Osamu;Kojiro, Masamichi
Background and Aims: Scirrhous hepatocellular carcinoma (SHCC) is characterized by diffuse fibrosis of the tumor, however, its clinicopathological features are not fully clarified. This study aimed to clarify the clinicopathological features of SHCC.Methods: Among 546 consecutively resected HCC without preoperative anticancer therapies, 25 SHCC were selected for the study and compared with 521 cases without scirrhous as the control.Results: SHCC accounted for 4.6% of cases. On diagnostic imagings, SHCC was frequently misdiagnosed as cholangiocarcinoma (CC), combined HCC-CC or metastatic carcinoma. Overall survival rate was significantly higher than the control. The average (+/- SD) tumor size of SHCC was 3.4 +/- 1.8 cm without significant difference to the control. The majority of SHCC (88%) were located close to the liver capsule. SHCC was characterized by stellate fibrosis (84%), no encapsulation (100%), no necrosis and hemorrhage (100%), intratumoral portal tracts (80%), remarkable lymphocyte infiltration (84%), clear cell change (84%), and hyaline bodies (52%). The number of alpha-smooth muscle actin-positive myofibroblast-like cells (activated stellate cells) in the tumor was about three times more than that in the control. Regarding the developmental mechanism of scirrhous change, a close correlation with unique tumor location and activation of stellate cells was suggested.Conclusion: SHCC presents with characteristic clinicopathological features and the recognition of SHCC is important for both clinicians and pathologists.